Search

You searched for "radiology"

350 results found

Prostate cancer

1 July 2015 | | URO - Urologic Oncology
Case 1 What is prostate specific antigen (PSA) and what is its function? According to the ERSPC Trial (at 13 years), what was the number needed to screen and diagnosed to prevent one prostate cancer death and what was the...

Ambulatory local anaesthetic implantation of percutaneous sacral nerve stimulators

11 July 2023 | | URO - Functional / Reconstructive Urology
Background The current treatment paradigm for detrusor overactivity (DO) and dysfunctional voiding (DV) includes conservative measures, pharmacotherapy, intravesical onabotulinum toxin A (Botox®), sacral nerve modulation (SNM / SNS) and urinary diversion as a last resort [1]. Incidence of DO is...

Intelligent triage: improving outpatient efficiency

13 March 2023 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Neurourology, URO - Paediatrics, URO - Core Urology, URO - Functional / Reconstructive Urology, URO - Technology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology
Background Improving outpatient (OP) efficiency and service structure is of paramount importance as the NHS seeks to manage ever increasing demand in the wake of the COVID-19 pandemic. As we re-establish services and attempt to clear the backlog, new ways...

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

8 November 2021 | | URO - Basic Science Research, URO - Urologic Oncology
Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...

25 Years of Prostate Cancer UK

8 February 2022 | | URO - Urologic Oncology
As leading men’s health charity, Prostate Cancer UK, celebrates its 25th anniversary, top researchers reflect on the huge progress in testing, treatment and support for men over the past 25 years. 25 years of beating prostate cancer together Matthew Hobbs,...

New techniques in UTI diagnosis

12 September 2023 | | URO - Functional / Reconstructive Urology, URO - Infection
Urinary tract infection (UTI) is a common reason for seeking medical care in both primary and secondary settings. Half of women will have at least one episode of cystitis in their lifetime, and a third of them will have experienced...

In conversation with Tim O’Brien

1 December 2020 | URO - Core Urology
We were delighted to catch up with Tim O’Brien, President of BAUS, about his career highlights and plans for the association. Can you tell us a little bit about what led you into the field of urology and the highlights...

Edward Canny Ryall: the lost urologist

1 January 2015 | | URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the BAUS Virtual Museum of the History of Urology which is part of the BAUS website (www.baus.org.uk). In the last article we looked...

Clinical trials 1

1 January 2017 | URO - Basic Science Research
Clinical Trials 2 is available here. Case 1 1. What are the levels of clinical evidence based on the 2009 definitions from the ‘Oxford CEBM’? 2. What is the null hypothesis? 3. What are type 1 and type 2 errors?...

DUS Annual Meeting 2025 – a story from Nyborg Strand

1 May 2026 | Urology News
13–15 November 2025 / Funen, Denmark Naomi Nadler, Urology Resident; Rose Laursen, Urology Resident; and Stine Hedegaard, Consultant Urologist, Department of Urology, Zealand University Hospital, Roskilde, Denmark. Every November, the urological community of Denmark migrates to the central island Funen...

A guide to local anaesthetic transperineal prostate biopsy

2 November 2023 | | URO - Urologic Oncology
In the UK, nearly 100,000 men undergo a prostate biopsy annually, a figure projected to double in the next decade [1]. In recent years, we have observed a paradigm shift in urological practice in numerous UK hospitals. The conventional transrectal,...

Benign prostatic hyperplasia: what are the benefits and harms of various surgical management options?

9 March 2020 | | URO - Functional / Reconstructive Urology, URO - Infection, URO - Neurourology, URO - Technology
Benign prostatic hyperplasia (BPH) is characterised by stromal and epithelial prostatic cell hyperplasia. The enlarged prostate may be associated with voiding and storage lower urinary tract symptoms (LUTS). These have been predominantly attributed to bladder outlet obstruction (BOO), assumed to...